CN115551855A - 半乳凝素-3的小分子抑制剂 - Google Patents
半乳凝素-3的小分子抑制剂 Download PDFInfo
- Publication number
- CN115551855A CN115551855A CN202180033194.3A CN202180033194A CN115551855A CN 115551855 A CN115551855 A CN 115551855A CN 202180033194 A CN202180033194 A CN 202180033194A CN 115551855 A CN115551855 A CN 115551855A
- Authority
- CN
- China
- Prior art keywords
- fluorophenyl
- triazol
- mmol
- diseases
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063020041P | 2020-05-05 | 2020-05-05 | |
| US63/020,041 | 2020-05-05 | ||
| PCT/US2021/030540 WO2021226002A1 (en) | 2020-05-05 | 2021-05-04 | Small molecule inhibitors of galectin-3 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115551855A true CN115551855A (zh) | 2022-12-30 |
Family
ID=76076509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180033194.3A Pending CN115551855A (zh) | 2020-05-05 | 2021-05-04 | 半乳凝素-3的小分子抑制剂 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12275720B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4146646A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7705884B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230006547A (cg-RX-API-DMAC10.html) |
| CN (1) | CN115551855A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021226002A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2631509A (en) * | 2023-07-04 | 2025-01-08 | Univ Liverpool | Compositions |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0401300D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel Galactoside Inhibitors of Galectins |
| SE0401301D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel 3-triazolyl-galactoside inhibitors of galectins |
| ES2652488T3 (es) | 2009-04-28 | 2018-02-02 | Galecto Biotech Ab | Nuevos inhibidores de galactósidos de galectinas |
| KR102231732B1 (ko) | 2012-10-10 | 2021-03-23 | 갈렉틴 테라퓨틱스, 인크. | 당뇨병성 신장병증 및 관련 질환의 치료를 위한 갈락토스 갈래의 탄수화물 화합물 |
| IN2015DN02573A (cg-RX-API-DMAC10.html) | 2012-10-31 | 2015-09-11 | Galecto Biotech Ab | |
| CA2970062C (en) | 2015-01-30 | 2023-02-28 | Galecto Biotech Ab | Alpha-d-galactoside inhibitors of galectins |
| CA3000924A1 (en) | 2015-11-09 | 2017-05-18 | Galecto Biotech Ab | Novel galactoside inhibitors of galectins |
| KR102626669B1 (ko) | 2017-05-12 | 2024-01-17 | 갈랙틴 사이언시즈, 엘엘씨 | 질환의 예방 및 치료를 위한 화합물 및 이의 용도 |
| CA3062649A1 (en) * | 2017-05-12 | 2018-11-15 | Galectin Sciences, Llc | Compounds for the treatment of systemic insulin resistance disorders and the use thereof |
| EP3807290B1 (en) | 2018-06-15 | 2022-03-30 | Bristol-Myers Squibb Company | Tetrahydropyran-based thiodisaccharide mimics as galectin-3 inhibitors |
-
2021
- 2021-05-04 US US17/921,653 patent/US12275720B2/en active Active
- 2021-05-04 WO PCT/US2021/030540 patent/WO2021226002A1/en not_active Ceased
- 2021-05-04 EP EP21727712.8A patent/EP4146646A1/en active Pending
- 2021-05-04 CN CN202180033194.3A patent/CN115551855A/zh active Pending
- 2021-05-04 JP JP2022567342A patent/JP7705884B2/ja active Active
- 2021-05-04 KR KR1020227042064A patent/KR20230006547A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021226002A1 (en) | 2021-11-11 |
| JP7705884B2 (ja) | 2025-07-10 |
| KR20230006547A (ko) | 2023-01-10 |
| US20230192672A1 (en) | 2023-06-22 |
| JP2023524996A (ja) | 2023-06-14 |
| EP4146646A1 (en) | 2023-03-15 |
| US12275720B2 (en) | 2025-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105916855B (zh) | 作为酪蛋白激酶1d/e抑制剂的取代的4,5,6,7-四氢吡唑并[1,5-a]吡嗪衍生物 | |
| TWI623530B (zh) | 雙環稠合之雜芳基或芳基化合物 | |
| CN104470925B (zh) | 作为激酶抑制剂的咪唑并三嗪甲腈 | |
| TW202508588A (zh) | Kras抑制劑 | |
| CN111606908A (zh) | Jak抑制剂化合物及其用途 | |
| WO2019075045A1 (en) | INHIBITORS WITH SMALL MOLECULES OF GALECTIN-3 | |
| WO2023001133A1 (zh) | Prmt5抑制剂 | |
| CN109689664B (zh) | 作为par4抑制剂的三环杂芳基取代的喹啉和氮杂喹啉化合物 | |
| JP7190513B2 (ja) | ガレクチン-3抑制剤を模したテトラヒドロピラン系チオ二糖類 | |
| KR102967859B1 (ko) | 갈렉틴-3의 소분자 억제제 | |
| JP7705884B2 (ja) | ガレクチン-3の低分子阻害剤 | |
| JP7772718B2 (ja) | ガレクチン-3阻害剤 | |
| CN121443603A (zh) | 能够用于治疗smarca4缺失型癌症的作为smarca2抑制剂的1,6-萘啶化合物 | |
| TW202245774A (zh) | 嘧啶或吡啶並雜環類腺苷受體抑制劑及其製備方法和用途 | |
| CN115551850A (zh) | 半乳凝素-3的小分子抑制剂 | |
| CN113166122A (zh) | 半乳糖凝集素-3的小分子抑制剂 | |
| HK40119081A (en) | Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof | |
| HK40113561A (en) | Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof | |
| HK40118199A (en) | Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof | |
| HK40113562A (en) | Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof | |
| HK40119082A (en) | Benzamides of pyrazolyl-amino-pyrimidinyl derivatives, and compositions and methods thereof | |
| HK40076948B (en) | Kras g12d inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |